Abstract
Background Genetic control of gene expression in asthma-related tissues is not well-characterized, particularly for African-ancestry populations, limiting advancement in our understanding of the increased prevalence and severity of asthma in those populations.
Objective To create novel transcriptome prediction models for asthma tissues (nasal epithelium and CD4+ T cells) and apply them in transcriptome-wide association study (TWAS) to discover candidate asthma genes.
Methods We developed and validated gene expression prediction databases for unstimulated CD4+ T cells (CD4+T) and nasal epithelium using an elastic net framework. Combining these with existing prediction databases (N=51), we performed TWAS of 9,284 individuals of African-ancestry to identify tissue-specific and cross-tissue candidate genes for asthma. For detailed Methods, please see the Supplemental Methods.
Results Novel databases for CD4+T and nasal epithelial gene expression prediction contain 8,351 and 10,296 genes, respectively, including four asthma loci (SCGB1A1, MUC5AC, ZNF366, LTC4S) not predictable with existing public databases. Prediction performance was comparable to existing databases and was most accurate for populations sharing ancestry with the training set (e.g. African ancestry). From TWAS, we identified 17 candidate causal asthma genes (adjusted P<0.1), including genes with tissue-specific (IL33 in nasal epithelium) and cross-tissue (CCNC and FBXW7) effects.
Conclusions Expression of IL33, CCNC, and FBXW7 may affect asthma risk in African ancestry populations by mediating inflammatory responses. The addition of CD4+T and nasal epithelium prediction databases to the public sphere will improve ancestry representation and power to detect novel gene-trait associations from TWAS.
Key Messages
From the largest African-ancestry TWAS of asthma to date (N=9,284), we identified 17 candidate causal asthma genes, including: nasal epithelial expression of IL33, and cross-tissue expression of CCNC and FBXW7.
We provide gene expression prediction databases for CD4+ T cell and nasal epithelial tissues built in African-ancestry populations, improving ancestry representation and power to detect novel gene-trait associations from TWAS.
Capsule Summary We developed novel gene expression prediction databases (CD4+ T cells, nasal airway epithelium) representing diverse populations across the African diaspora and identified 17 candidate causal asthma genes from TWAS.
Competing Interest Statement
A.H.L. has research grants with National Institutes of Health, ResMed and OM Pharma, receives non-monetary research support from ResMed and Revenio, and is a Consultant for ThermoFisher Scientific, AstraZeneca, and OM Pharma. All funds are paid to the University of Colorado. C.R.G. owns stock in 23andMe, Inc. K.C.B. declares Royalties from UpToDate. The remaining authors declare no competing interests.
Funding Statement
This work was supported by the National Institutes of Health (R01HL104608, R01AI132476), and the NHLBI BioData Catalyst Fellowship. The funding sources were not involved in the study design; data collection, analysis, or interpretation; writing the report; or in the decision to submit the article for publication.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The University of Colorado (IRB#: 17-1807, COMIRB#: 15-2148), Johns Hopkins University (IRB00179053), University of Chicago (IRB18-0466-CR001), National Institutes of Health (IRB#: P184385), University of West Indies (IRB#: 190604-A), University of Bahia (IRB#: 3.302.487) and University of Ibadan (IRB18-0840) Institutional Review Boards gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Funding Statement This work was supported by the National Institutes of Health (R01HL104608, R01AI132476), and an NHLBI BioData Catalyst Fellowship. The funding sources were not involved in the study design; data collection, analysis, or interpretation; writing the report; or in the decision to submit the article for publication.
Disclosure of Potential Conflicts of Interest A.H.L. has research grants with National Institutes of Health, ResMed and OM Pharma, receives non-monetary research support from ResMed and Revenio, and is a Consultant for ThermoFisher Scientific, AstraZeneca, and OM Pharma. All funds are paid to the University of Colorado. C.R.G. owns stock in 23andMe, Inc. K.C.B. declares Royalties from UpToDate. The remaining authors declare no competing interests.
Abbreviations
- BAGS
- Barbados Asthma Genetics Study
- CAAPA
- Consortium on Asthma among African-ancestry Populations in the Americas
- eQTL
- expression quantitative trait locus
- TWAS
- transcriptome-wide association study
- GWAS
- genome-wide association study
- RNAseq
- RNA sequencing
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.